Physician profile

Ala Alkhatib

Pulmonary Disease · Brighton, MA

NPI 1912313388

$2,121.65

in general payments reported to CMS, 2019-2025

20 companies · $397 in 2025

The $397 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,131.97

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boehringer Ingelheim Pharmaceuticals, INC. $386.23 2020-2025
Glaxosmithkline, LLC. $340.42 2020-2025 Trelegy Ellipta, Nucala
Mallinckrodt Hospital Products INC. $319.32 2021-2024 Acthar
Astrazeneca Pharmaceuticals Lp $319.11 2023-2025 Breztri, Fasenra, Tezspire
Genzyme Corporation $194.06 2021-2025
Takeda Pharmaceuticals U.S.A., INC. $119.52 2021-2023 Glassia
Avanos Medical $86.82 2023 On-Q* Pump and Accessories
Polynovo North America LLC $58.82 2025 Novosorb Btm
Abbvie INC. $45.09 2021-2022
Bayer Healthcare Pharmaceuticals INC. $42.35 2020
Amgen INC. $27.96 2025 Tezspire
Philips North America LLC $25.75 2020
Gilead Sciences, INC. $24.79 2024
Insmed, INC. $22.65 2024 Arikayce
Grifols USA, LLC $22.47 2025 Prolastin-C Liquid
Show all 20 companies
CompanyGeneral paymentsYearsTop products
United Therapeutics Corporation $21.84 2024 Tyvaso
Genentech USA, INC. $21.32 2020
Ani Pharmaceuticals, INC. $18.48 2023 Purified Cortrophin Gel
Electromed, INC. $13.90 2024 Smartvest
Intuitive Surgical, INC. $10.75 2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ala Alkhatib

$2,121.65

in general payments reported 2019-2025

Years
2020-2025
Top company
Boehringer Ingelheim Pharmaceuticals, INC.
Context
The $397 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/816167/ala-alkhatib

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.